Advances in covalent drug discovery

L Boike, NJ Henning, DK Nomura - Nature Reviews Drug Discovery, 2022 - nature.com
Covalent drugs have been used to treat diseases for more than a century, but tools that
facilitate the rational design of covalent drugs have emerged more recently. The purposeful …

Nrf2/Keap1/ARE signaling: Towards specific regulation

AV Ulasov, AA Rosenkranz, GP Georgiev, AS Sobolev - Life Sciences, 2022 - Elsevier
The Nrf2 transcription factor governs the expression of hundreds genes involved in cell
defense against oxidative stress, the hallmark of numerous diseases such as …

Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages

MC Runtsch, S Angiari, A Hooftman, R Wadhwa… - Cell metabolism, 2022 - cell.com
The Krebs cycle-derived metabolite itaconate and its derivatives suppress the inflammatory
response in pro-inflammatory" M1" macrophages. However, alternatively activated" M2" …

Mitochondrial TCA cycle metabolites control physiology and disease

I Martínez-Reyes, NS Chandel - Nature communications, 2020 - nature.com
Mitochondria are signaling organelles that regulate a wide variety of cellular functions and
can dictate cell fate. Multiple mechanisms contribute to communicate mitochondrial fitness to …

[HTML][HTML] An activity-guided map of electrophile-cysteine interactions in primary human T cells

EV Vinogradova, X Zhang, D Remillard, DC Lazar… - Cell, 2020 - cell.com
Electrophilic compounds originating from nature or chemical synthesis have profound effects
on immune cells. These compounds are thought to act by cysteine modification to alter the …

Emerging and re-emerging warheads for targeted covalent inhibitors: applications in medicinal chemistry and chemical biology

M Gehringer, SA Laufer - Journal of medicinal chemistry, 2018 - ACS Publications
Targeted covalent inhibitors (TCIs) are designed to bind poorly conserved amino acids by
means of reactive groups, the so-called warheads. Currently, targeting noncatalytic cysteine …

Transcription factor NRF2 as a therapeutic target for chronic diseases: a systems medicine approach

A Cuadrado, G Manda, A Hassan, MJ Alcaraz… - Pharmacological …, 2018 - Elsevier
Abstract Systems medicine has a mechanism-based rather than a symptom-or organ-based
approach to disease and identifies therapeutic targets in a nonhypothesis-driven manner. In …

Dimethyl fumarate targets GAPDH and aerobic glycolysis to modulate immunity

MD Kornberg, P Bhargava, PM Kim, V Putluri… - Science, 2018 - science.org
Activated immune cells undergo a metabolic switch to aerobic glycolysis akin to the Warburg
effect, thereby presenting a potential therapeutic target in autoimmune disease. Dimethyl …

Coupling Krebs cycle metabolites to signalling in immunity and cancer

DG Ryan, MP Murphy, C Frezza, HA Prag… - Nature …, 2019 - nature.com
Metabolic reprogramming has become a key focus for both immunologists and cancer
biologists, with exciting advances providing new insights into the mechanisms underlying …

Electrophilic PROTACs that degrade nuclear proteins by engaging DCAF16

X Zhang, VM Crowley, TG Wucherpfennig… - Nature chemical …, 2019 - nature.com
Ligand-dependent protein degradation has emerged as a compelling strategy to
pharmacologically control the protein content of cells. So far, however, only a limited number …